Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 480.00
Ask: 500.00
Change: -5.00 (-1.01%)
Spread: 20.00 (4.167%)
Open: 495.00
High: 495.00
Low: 490.00
Prev. Close: 495.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

20 Jan 2017 07:00

RNS Number : 6651U
BrainJuicer Group PLC
20 January 2017
 

 

 

Press Release

20 January 2017

 

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer", or "the Company")

 

Trading Update

 

BrainJuicer (AIM: BJU) today releases the following update on trading during the 12 month period ended 31st December 2016.

 

BrainJuicer traded strongly during 2016, regaining momentum after the modest growth of the 2 previous years. For the 12 month period, Gross Profit, our main top line indicator, increased by some 27% to approximately £25.6m, driven primarily by continued strong progress by our US business and an encouraging recovery in Continental Europe. Excluding the impact of exchange rate movements the increase in Gross Profit was some 15%.

 

In terms of products, our Advertising Testing and Brand Tracking services again delivered strong growth. In aggregate Gross Profit from these comparatively high margin and scalable quantitative services rose by around 80%, and represented around 39% of BrainJuicer's total Gross Profit, compared with 27% in 2015.

 

Our System1 creative advertising agency, launched in early 2016, is making an encouraging start with costs net of initial revenues in 2016 on budget at £0.3m.

 

Cost increases, and in particular central overheads, were held well below the rate of Gross Margin growth. Even after a much higher level of bonus payments, compared with a negligible payout in 2015, Pre-tax profit for 2016 is expected to be some 37% higher at around £6.2m, (2015: £4.5m) after a share-based payments charge of £0.5m (2015: £0.2m)

 

BrainJuicer again proved highly cash generative during 2016. £5.2m was returned to shareholders over the 12 months via ordinary and special dividends and share buy-backs, but the Company still ended 2016 with a cash balance of £7.8m, equivalent to 63 pence per share, compared with £6.4m at end December 2015. BrainJuicer has no debt.

 

As previously announced, BrainJuicer is changing its financial year end from 31st December to 31st March. During this transition year, the announcement of unaudited results for 2016 on 9th February 2017 will be followed by audited results for the 15 months to 31st March 2017, which will be announced in June 2017.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

The Company can be found at www.brainjuicer.com.

 

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0)20 7043 1000

 

John Kearon, Chief Executive Officer

 

James Geddes, Chief Financial Officer

 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Cameron Duncan / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKUBRBAAAAAR
Date   Source Headline
24th Feb 20177:00 amRNSNotice of GM
10th Feb 20173:46 pmRNSExercise of Options
9th Feb 20177:00 amRNSResults for the 12 months ended 31 December 2016
7th Feb 20177:00 amRNSBoard Appointment
20th Jan 20177:00 amRNSTrading Update
9th Dec 20167:00 amRNSTrading Update
1st Dec 201612:45 pmRNSTotal Voting Rights
1st Nov 20165:34 pmRNSTransaction in Own Shares
1st Nov 20161:35 pmRNSTotal Voting Rights
13th Oct 20165:34 pmRNSTransaction in Own Shares
12th Oct 20161:44 pmRNSTransaction in Own Shares
4th Oct 20167:00 amRNSDirectorPDMR Dealing and Transaction in Own Shares
30th Sep 20165:15 pmRNSTransaction in Own Shares
27th Sep 20164:57 pmRNSExercise of Options, PDMR Shareholding
22nd Sep 20167:00 amRNSExercise of Options and Transaction in Own Shares
22nd Sep 20167:00 amRNSTransaction in Own Shares
20th Sep 20166:23 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSTransaction in Own Shares
16th Sep 20167:00 amRNSInterim Results
16th Sep 20167:00 amRNSDividends and Share Buyback
9th Sep 20164:39 pmRNSHolding(s) in Company
9th Sep 20161:20 pmRNSHolding(s) in Company
26th Aug 201611:42 amRNSHolding(s) in Company
16th Aug 20164:15 pmRNSAdditional Listing
15th Jul 20167:00 amRNSTrading Update
20th Jun 20164:40 pmRNSTransaction in Own Shares
6th Jun 20164:45 pmRNSDirector Dealing
6th Jun 201611:17 amRNSDirector Dealing
3rd Jun 20162:17 pmRNSHolding(s) in Company
2nd Jun 20166:02 pmRNSDirector Dealing and Transaction in Own Shares
18th May 20165:46 pmRNSDirector Dealing and Transaction in Own Shares
6th May 201612:19 pmRNSResult of AGM
4th May 20163:55 pmRNSTransaction in Own Shares
22nd Apr 20163:17 pmRNSHolding(s) in Company
22nd Apr 20161:07 pmRNSHolding(s) in Company
22nd Apr 20167:00 amRNSTransaction in Own Shares and Director Dealing
21st Apr 201611:41 amRNSDistributable Reserves
8th Apr 20165:54 pmRNSAnnual Report and Notice of AGM
31st Mar 20167:20 amRNSShare Buyback
21st Mar 20167:00 amRNSChange of accounting reference date
21st Mar 20167:00 amRNSDividend Declaration
21st Mar 20167:00 amRNSFinal Results
19th Feb 20163:25 pmRNSHolding(s) in Company
17th Feb 20164:16 pmRNSHolding(s) in Company
17th Feb 20167:00 amRNSHolding(s) in Company
12th Feb 201611:17 amRNSHolding(s) in Company
18th Jan 20167:00 amRNSTrading Update
15th Jan 20161:31 pmRNSNotification in accordance with FRS 101
30th Nov 20156:28 pmRNSHolding(s) in Company
12th Nov 20159:56 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.